港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

長風藥業

28.080

-1.100-3.77%

成交量：13.75萬

成交額：389.93萬

市值：115.68億

市盈率：- -

高：29.280

開：29.280

低：28.000

收：29.180

52周最高：48.800

52周最低：27.200

股本：4.12億

香港流通股本：3.02億

量比：0.47

換手率：0.05%

股息：- -

股息率：- -

淨資產收益率：-5.62%

總資產收益率：-5.30%

市淨率：11.05

市盈率(LYR):- -

市銷率: 17.54

資料載入中...

總覽公司新聞公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞

從本土突圍到全球破局，長風藥業港交所上市，劍指吸入製劑高地

200億，中國藥谷又跑出一個IPO

周律微金融

長風速遞丨長風藥業治療肺氣腫領域的微創介入器械完成首例入組

中国医药创新促...

港股異動 | 長風藥業(02652)午前漲近3% 公司治療肺氣腫領域的微創介入器械完成首例入組

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hant/stock/02652"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02652","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02652\",,,,,undefined,":{"symbol":"02652","market":"HK","secType":"STK","nameCN":"長風藥業","latestPrice":28.08,"timestamp":1761293295066,"preClose":29.18,"halted":0,"volume":137500,"delay":0,"floatShares":302223586,"shares":411978387,"eps":0,"marketStatus":"未開盤","change":-1.1,"latestTime":"10-24 16:08:15","open":29.28,"high":29.28,"low":28,"amount":3899340,"amplitude":0.043866,"askPrice":28.3,"askSize":500,"bidPrice":28.08,"bidSize":500,"shortable":0,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1761528600000},"marketStatusCode":0,"adr":0,"listingDate":1759852800000,"exchange":"SEHK","adjPreClose":29.18,"openAndCloseTimeList":[[1761269400000,1761278400000],[1761282000000,1761292800000]],"volumeRatio":0.46717223200967356,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02652\",,,,,undefined,":{"symbol":"02652","floatShares":302223586,"roa":"-5.30%","roe":"-5.62%","lyrEps":0,"volumeRatio":0.46717223200967356,"shares":411978387,"dividePrice":0,"high":29.28,"amplitude":0.043866,"preClose":29.18,"low":28,"week52Low":27.2,"pbRate":"11.05","psRate":"17.54","week52High":48.8,"institutionHeld":0,"latestPrice":28.08,"eps":0,"divideRate":0,"volume":137500,"delay":0,"ttmEps":0,"open":29.28,"prevYearClose":14.75,"prevWeekClose":29.46,"prevMonthClose":14.75,"prevQuarterClose":14.75,"fiveDayClose":29.46,"twentyDayClose":14.75,"sixtyDayClose":14.75},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02652\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02652\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02652\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02652\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02652","date":"2025-10-24","current":382.04749,"percent":0.166667,"low":-293.764894,"twenty":383.954109,"median":395.798507,"eighty":407.879105,"high":450.433063,"avg":347.113431,"sd":185.901651,"marketCap":11568353106},"quantilePoints":[{"date":"2025-10-10","current":420.512992,"twenty":-8.053739,"median":420.512992,"eighty":438.465035,"marketCap":12738371726},{"date":"2025-10-17","current":400.969089,"twenty":380.917252,"median":393.18793,"eighty":412.695431,"marketCap":12136883281},{"date":"2025-10-24","current":382.04749,"twenty":383.954109,"median":395.798507,"eighty":407.879105,"marketCap":11568353106}],"updateTime":1761472408197},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02652\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2577721841","title":"從本土突圍到全球破局，長風藥業港交所上市，劍指吸入製劑高地","url":"https://stock-news.laohu8.com/highlight/detail?id=2577721841","media":"健识局","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577721841?lang=zh_tw&edition=fundamental","pubTime":"2025-10-20 20:22","pubTimestamp":1760962957,"startTime":"0","endTime":"0","summary":"长风药业成立于2013年，主要专注于呼吸系统疾病领域药物的研发、生产和销售。市场层面，2024年，呼吸系统疾病占全球医药市场约6.5%。以中国布地奈德吸入药物市场为例，2024年按销量计，长风药业CF017已占据约16%的市场份额，成为国产企业中的重要参与者。吸入制剂技术门槛高，长风药业不仅是少数几家拥有广泛吸入制剂产品组合的公司之一，也是国内少有的立足中国、面向全球的吸入制剂研发企业。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251020215450a6c3e9b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251020215450a6c3e9b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02652"],"gpt_icon":0},{"id":"2576029690","title":"200億，中國藥谷又跑出一個IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2576029690","media":"周律微金融","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576029690?lang=zh_tw&edition=fundamental","pubTime":"2025-10-19 00:01","pubTimestamp":1760803270,"startTime":"0","endTime":"0","summary":"此次长风药业成功IPO，不仅是一家创新药企成长的里程碑，更令苏州生物医药“IPO军团”再添一员。两位美籍博士带队，靠卖哮喘药干出一个IPO闯关IPO这一路，长风医药走得一波三折。其核心产品CF017是中国销量最高的吸入药物类别。2021年5月获批后，迅速纳入国家集采，凭借“价格优势+疗效稳定”快速放量，长风药业的市场推广体系使CF017成功覆盖了中国超过一万家医疗机构。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251019001200a6c07b8f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251019001200a6c07b8f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02652","BK1161","06978","09939","BK1574","BK1515"],"gpt_icon":0},{"id":"2576055537","title":"長風速遞丨長風藥業治療肺氣腫領域的微創介入器械完成首例入組","url":"https://stock-news.laohu8.com/highlight/detail?id=2576055537","media":"中国医药创新促...","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576055537?lang=zh_tw&edition=fundamental","pubTime":"2025-10-17 17:39","pubTimestamp":1760693947,"startTime":"0","endTime":"0","summary":"本文转载自长风药业——面向肺气肿的微创介入治疗进入临床验证新阶段2025年10月17日，中国广州— 近日，长风药业股份有限公司自研支气管活瓣肺减容装置成功完成首例受试者入组，本临床验证阶段由此正式拉开帷幕，旨在为肺气肿等慢阻肺相关人群拓展一条微创介入治疗路径。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251017184912a464ff00&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251017184912a464ff00&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02652"],"gpt_icon":0},{"id":"2576283704","title":"港股異動 | 長風藥業(02652)午前漲近3% 公司治療肺氣腫領域的微創介入器械完成首例入組","url":"https://stock-news.laohu8.com/highlight/detail?id=2576283704","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576283704?lang=zh_tw&edition=fundamental","pubTime":"2025-10-17 11:49","pubTimestamp":1760672960,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，长风药业午前涨近3%，截至发稿，涨2.74%，报29.2港元，成交额536.45万港元。消息面上，据长风药业官微消息，近日，长风药业自研支气管活瓣肺减容装置成功完成首例受试者入组，本临床验证阶段由此正式拉开帷幕，旨在为肺气肿等慢阻肺相关人群拓展一条微创介入治疗路径。据介绍，肺气肿患者常见动态过度充气与活动受限，现有疗法在实现长效管理与显著改善生活质量方面，存在大量未满足的临床需求。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1356258.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02652"],"gpt_icon":0}],"pageSize":4,"totalPage":13,"pageCount":1,"totalSize":50,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/02652\",params:#limit:6,delay:false,,,undefined,":[]}}